LOTUSEYE

The stock has been placed in Additional Surveillance Measure (ASM) list LTASM - I (13).

Lotus Eye Hospital And Institute Ltd.

NSE: LOTUSEYE

BSE: 532998

Sector: Healthcare

Industry Group: Healthcare Services

Industry: Hospital

115.56-2.4 (-2.02%)

21 Aug, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

13.1 / 100

Value Score

14.4 / 100

Price Momentum Score

63.4 / 100

QVM Score

12.7 / 100

Key Metrics

Market Cap

240.32

P/E (TTM)

1609.64

P/B

4.00

P/S (TTM)

4.20

EV/EBITDA

52.01

CAPE (5Y)

102.78

ROE (TTM)

0.13

ROCE (TTM)

-0.52

ROA (TTM)

0.11

Avg 3Y ROE

2.12

Earnings 3Y CAGR

-65.63

Sales 3Y CAGR

6.25

Sales 5Y CAGR

11.29

Debt/Equity

0.26

Consensus TP

Strong Buy %

Promoter Holding

40.14

Pledged %

87.15

Stock Analysis

Fundamental analysis overview of Lotus Eye Hospital And Institute Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.26 as on 30 Jun 2026 and Debt to Equity increased marginally by 0.17 in the last 1 year

What is Debt to Equity?

Negative

Expensive and at a premium to industry median P/E

PE TTM of 1609.64 indicates that the stock is expensive on a standalone basis and is at a 3059.25% premium to industry median P/E

What is P/E Ratio?

Median: 50.95

Value 1609.64

14.291609.64

Low but stable ROE

The company reported low ROE of 0.13% for 12-month ended 30 Jun 2026 and ROE declined marginally by -111 bps from 1 year ago

What is ROE (FY)?

Low but stable operating margin

The company reported low operating margin of 0.5% for 12-month ended 30 Jun 2026 and operating margin declined marginally by -44 bps from 1 year ago

What is Operating profit margin?

Moderate revenue growth but lower than median growth of industry

The company delivered moderate revenue growth of 14.08% for 12-month ended 30 Jun 2026 but the growth was 4.0 percentage points lower than median growth of industry

What is Sales growth (1Y)?

Median: 18.08

Value 14.08

-26.8103.8

Low EPS growth and lower than median growth of industry

The company delivered moderate EPS growth of -76.15% for 12-month ended 30 Jun 2026 and the growth was 88.28 percentage points lower than median growth of industry

What is EPS growth (1Y)?

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Company's earnings are of moderate quality

Earnings quality score of 61.2 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

61.2 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for Lotus Eye Hospital And Institute Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Lotus Eye Hospital And Institute Ltd. Shareholding Pattern

Quarterly breakdown of Lotus Eye Hospital And Institute Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	57.68	57.68	57.68	57.71	57.74	57.74	57.74	57.74	57.74	57.74	57.88	58.14	58.17	58.43	57.58	56.58	41.40	40.24	40.03	40.14	40.22	40.39	40.64	40.67	40.14	40.14
Indian Promoter	57.68	57.68	57.68	57.71	57.74	57.74	57.74	38.96	38.96	38.96	39.10	39.36	39.39	39.66	38.80	37.80	22.62	21.46	21.25	21.36	21.44	23.16	31.02	31.05	37.39	37.39
Foreign Promoter	-	-	-	-	-	-	-	18.78	18.78	18.78	18.78	18.78	18.78	18.78	18.78	18.78	18.78	18.78	18.78	18.78	18.78	17.23	9.61	9.61	2.75	2.75
Institutions	-	-	-	-	-	-	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.01	0.00	-
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.01	0.00	0.00
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	42.32	42.32	42.32	42.29	42.26	42.26	42.26	42.26	42.26	42.26	42.12	41.86	41.83	41.57	42.42	43.42	58.60	59.76	59.97	59.86	59.78	59.60	59.36	59.33	59.86	59.87
Bodies Corporate	10.00	10.32	10.80	10.75	10.77	10.68	10.67	0.99	1.05	1.06	16.41	16.86	16.88	16.81	16.97	16.90	12.52	12.34	13.44	14.12	14.62	15.03	12.86	13.35	13.49	13.77
Others (incl. Retail) No. of shareholders	32.32 5,962	32.00 5,800	31.52 5,867	31.54 5,576	31.49 5,925	31.58 6,290	31.59 6,138	41.27 6,187	41.21 6,791	41.20 6,988	25.71 7,373	25.00 7,376	24.95 7,305	24.76 7,386	25.45 7,612	26.52 8,267	46.08 12,454	47.42 11,711	46.53 12,458	45.74 11,688	45.16 11,460	44.57 11,067	46.50 10,739	45.98 10,203	46.37 9,900	46.10 9,593

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

Lotus Eye Hospital And Institute Ltd. is not part of any tracked index.

Prominent Investor Holdings

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Lotus Eye Hospital And Institute Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
S Rajkumar Promoter	July-2024	Market Sale (Disposal) 6th Jul 2024	0.83 %	₹ 57.19	1.31 lac	₹ 74.89 lac
S Rajkumar Promoter	June-2024	Market Sale (Disposal) 20th Jun 2024	1.36 %	₹ 57.04	1.09 lac	₹ 62.45 lac
S Rajkumar Promoter	March-2024	Market Sale (Disposal) 12th Mar 2024	16.55 %	₹ 54.87	31.58 lac	₹ 17.33 cr
S Rajkumar Promoter	December-2023	Market Sale (Disposal) 6th Dec 2023	17.54 %	₹ 84.95	2.07 lac	₹ 1.76 cr
S Rajkumar Promoter	June-2023	Market Purchase (Acquisition) 20th Jun 2023	18.24 %	₹ 83.98	19.66 k	₹ 16.51 lac
S Rajkumar Promoter	June-2023	Market Purchase (Acquisition) 13th Jun 2023	18.13 %	₹ 79.50	24.11 k	₹ 19.16 lac
Dr. K.S. RAMALINGAM Director	April-2021	Market Purchase (Acquisition) 1st Apr 2021	0.56 %	₹ 38.00	51.65 k	₹ 19.63 lac
MS. SANGEETHA SUNDARAMOORTHY Promoter & Director	March-2021	Market Purchase (Acquisition) 9th Mar 2021	1.10 %	₹ 37.08	6.48 k	₹ 2.40 lac

Corporate Actions

History of Lotus Eye Hospital And Institute Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 0.50/share
Record date: 18th Sep 2023Ex-date: 18th Sep 2023
Announced on: 24th May 2023
Dividend₹ 0.50/share
Record date: 10th Sep 2022Ex-date: 8th Sep 2022
Announced on: 25th May 2022
Dividend₹ 0.50/share
Record date: 10th Sep 2021Ex-date: 8th Sep 2021
Announced on: 30th Jun 2021
Dividend₹ 0.50/share
Record date: 17th Sep 2018Ex-date: 14th Sep 2018
Announced on: 29th May 2018
Dividend₹ 0.50/share
Record date: 3rd Aug 2017Ex-date: 2nd Aug 2017
Announced on: 27th May 2017

Company Profile

Overview of Lotus Eye Hospital And Institute Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Lotus Eye Hospital and Institute Limited is an India-based company, which is engaged in the business of healthcare activities. The Company is engaged in the field of ophthalmology (eye) and its related operations. It resolves a range of eye problems, such as refractive, cataract, cornea infections, ...

Key personnel

Mr. Ramanujam Reghunathan

Chief Financial Officer

Mr. Prathish S

Compliance Officer, Company Secretary

Dr. Kavetha SundaramoorthyD

Non-Executive Chairman of the Board

Ms. Sangeetha K. SundaramoorthyD

Managing Director, Executive Director

Dr. Kuttapalayam Songappan RamalingamD

Non-Executive Non-Independent Director

Mr. Perumalsamy MahendranD

Non-Executive Independent Director

Dr. Sengodagounder NatesanD

Non-Executive Independent Director

Mr. Karthik VeeramaniD

Non-Executive Independent Director

Incorporated on

14 Mar 1997

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

IPO date

11 Jul 2008

Free Float

61,76,439

Website

https://www.lotuseye.org/

Phone no.

+914224229900

Address

770/12 Avinashi Road,, Civil Aerodrome post,, COIMBATORE, 641014, India

Frequently Asked Questions

What is the current share price of Lotus Eye Hospital And Institute Ltd.?

The current share price of Lotus Eye Hospital And Institute Ltd. is ₹ 115.56 as of 21 Aug 2026.

What is the market capitalisation of Lotus Eye Hospital And Institute Ltd.?

The market capitalisation of Lotus Eye Hospital And Institute Ltd. stands at ₹ 240.32 Cr.

What is the PE ratio of Lotus Eye Hospital And Institute Ltd.?

The Price-to-Earnings (PE) ratio of Lotus Eye Hospital And Institute Ltd. is 1,609.64 as of the latest trailing twelve months data.

What is the ROE and ROCE of Lotus Eye Hospital And Institute Ltd.?

Lotus Eye Hospital And Institute Ltd. has a Return on Equity (ROE) of 0.13% and a Return on Capital Employed (ROCE) of -0.52% as per the latest financial reports.

What is the 52-week high and low of Lotus Eye Hospital And Institute Ltd.?

The 52-week high of Lotus Eye Hospital And Institute Ltd. is - and the 52-week low is -.

What is the dividend yield of Lotus Eye Hospital And Institute Ltd.?

The dividend yield of Lotus Eye Hospital And Institute Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Lotus Eye Hospital And Institute Ltd.?

Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 46.10% of Lotus Eye Hospital And Institute Ltd. shares.

What sector does Lotus Eye Hospital And Institute Ltd. belong to?

Lotus Eye Hospital And Institute Ltd. operates in the Healthcare sector.

What is the beta of Lotus Eye Hospital And Institute Ltd.?

The beta of Lotus Eye Hospital And Institute Ltd. is 0.90, indicating its price volatility relative to the broader market. Over the past 1 year, Lotus Eye Hospital And Institute Ltd. has delivered an absolute return of 52.59%.

What is the RSI of Lotus Eye Hospital And Institute Ltd.?

The 14-day Relative Strength Index (RSI) of Lotus Eye Hospital And Institute Ltd. is 44.52, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Lotus Eye Hospital And Institute Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Lotus Eye Hospital And Institute Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Holdings and Presence

Corporate Actions

Company Profile